Sa1853 - Predictors of Clinical and Endoscopic Response with Vedolizumab for the Treatment of Moderately-Severely Active Ulcerative Colitis: Results from the us Victory Consortium

Autor: Dulai, Parambir, Meserve, Joseph D., Hartke, Justin G., Chilukuri, Prianka, Chaudrey, Khadija, Koliani-Pace, Jenna L., Kochhar, Gursimran, Parikh, Malav P., Shmidt, Eugenia, Hirten, Robert, Luo, Michelle, Barocas, Morris, Lasch, Karen, Sultan, Keith, Swaminath, Arun, Bohm, Matthew, Lukin, Dana J., Hudesman, David, Shen, Bo, Siegel, Corey A., Sands, Bruce E., Colombel, Jean Frederic, Kane, Sunanda V., Loftus, Edward V., Singh, Siddharth, Sandborn, William J., Boland, Brigid S.
Zdroj: In Gastroenterology April 2017 152(5) Supplement 1:S371-S371
Databáze: ScienceDirect